|
|
Volumn 1, Issue 3, 2009, Pages 234-236
|
|
A polypill is the solution to the pharmacological management of cardiovascular risk: No
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
ANTITHROMBOCYTIC AGENT;
HYPOCHOLESTEROLEMIC AGENT;
ARTICLE;
CARDIOVASCULAR DISEASE;
CLINICAL PRACTICE;
DRUG COMBINATION;
ETHNOLOGY;
FEMALE;
HUMAN;
LIFE EXPECTANCY;
MALE;
META ANALYSIS;
METHODOLOGY;
NEW ZEALAND;
PATIENT COMPLIANCE;
PRIMARY PREVENTION;
RISK ASSESSMENT;
RISK FACTOR;
SECONDARY PREVENTION;
DOSE RESPONSE;
LIFESTYLE;
NOTE;
PRACTICE GUIDELINE;
ANTICHOLESTEREMIC AGENTS;
ANTIHYPERTENSIVE AGENTS;
CARDIOVASCULAR DISEASES;
DRUG COMBINATIONS;
FEMALE;
HUMANS;
LIFE EXPECTANCY;
MALE;
MEDICATION ADHERENCE;
META-ANALYSIS AS TOPIC;
NEW ZEALAND;
PHYSICIAN'S PRACTICE PATTERNS;
PLATELET AGGREGATION INHIBITORS;
PRIMARY PREVENTION;
RISK ASSESSMENT;
RISK FACTORS;
SECONDARY PREVENTION;
DOSE-RESPONSE RELATIONSHIP, DRUG;
LIFE STYLE;
PRACTICE GUIDELINES AS TOPIC;
|
|
EID: 79957809595
PISSN: 11726164
EISSN: 11726156
Source Type: Journal
DOI: 10.1071/hc09234 Document Type: Note |
|
Times cited : (2)
|
|
References (8)
|
